-
1
-
-
39849100878
-
Child-Pugh-Turcott versus MELD score for predicting survival in a retrospective cohort of black African cirrhotic patients
-
K.A. Attia, K.C. Ackoundou-N'guessan, A.T. N'dri-yoman, A.K. Mahassadi, E. Messou, Y.F. Bathaix, and Y.H. Kissi Child-Pugh-Turcott versus MELD score for predicting survival in a retrospective cohort of black African cirrhotic patients World J. Gastroenterol. 14 2 2008 286 291
-
(2008)
World J. Gastroenterol.
, vol.14
, Issue.2
, pp. 286-291
-
-
Attia, K.A.1
Ackoundou-N'Guessan, K.C.2
N'Dri-Yoman, A.T.3
Mahassadi, A.K.4
Messou, E.5
Bathaix, Y.F.6
Kissi, Y.H.7
-
2
-
-
0023933449
-
Hepatitis B virus. The major etiology of hepatocellular carcinoma
-
R.P. Beasley Hepatitis B virus. The major etiology of hepatocellular carcinoma Cancer 61 1998 1942 1956
-
(1998)
Cancer
, vol.61
, pp. 1942-1956
-
-
Beasley, R.P.1
-
4
-
-
33745542596
-
Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B
-
H.L. Chan, A.M. Chim, J.T. Lau, A.Y. Hui, V.W. Wong, and J.J. Sung Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B Am. J. Gastroenterol. 101 7 2006 1516 1523
-
(2006)
Am. J. Gastroenterol.
, vol.101
, Issue.7
, pp. 1516-1523
-
-
Chan, H.L.1
Chim, A.M.2
Lau, J.T.3
Hui, A.Y.4
Wong, V.W.5
Sung, J.J.6
-
5
-
-
77957173732
-
Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis
-
K. Das, K. Das, S. Datta, S. Pal, J.R. Hembram, G.K. Dhali, A. Santra, and A. Chowdhury Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis Liver Int. 30 2010 1033 1042
-
(2010)
Liver Int.
, vol.30
, pp. 1033-1042
-
-
Das, K.1
Das, K.2
Datta, S.3
Pal, S.4
Hembram, J.R.5
Dhali, G.K.6
Santra, A.7
Chowdhury, A.8
-
6
-
-
28844490547
-
Natural history and prognostic indicators of survival in cirrhosis: A systemic review of 118 studies
-
G. D'Amico, G. Garcia-Tsao, and L. Pagliaro Natural history and prognostic indicators of survival in cirrhosis: a systemic review of 118 studies J. Hepatol. 44 2006 217 231
-
(2006)
J. Hepatol.
, vol.44
, pp. 217-231
-
-
D'Amico, G.1
Garcia-Tsao, G.2
Pagliaro, L.3
-
7
-
-
0026658646
-
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
-
F.E. de Jongh, H.L. Janssen, R.A. de Man, W.C. Hop, S.W. Schalm, and M. van Blankenstein Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver Gastroenterology 103 1992 1630 1635
-
(1992)
Gastroenterology
, vol.103
, pp. 1630-1635
-
-
De Jongh, F.E.1
Janssen, H.L.2
De Man, R.A.3
Hop, W.C.4
Schalm, S.W.5
Van Blankenstein, M.6
-
8
-
-
0025981670
-
Natural history and prognostic factors for chronic hepatitis type B
-
G. Fattovich, L. Brollo, G. Giustina, F. Noventa, P. Pontisso, A. Alberti, G. Realdi, and A. Ruol Natural history and prognostic factors for chronic hepatitis type B Gut 32 1991 294 298
-
(1991)
Gut
, vol.32
, pp. 294-298
-
-
Fattovich, G.1
Brollo, L.2
Giustina, G.3
Noventa, F.4
Pontisso, P.5
Alberti, A.6
Realdi, G.7
Ruol, A.8
-
9
-
-
17744377963
-
Predicting the prognosis of chronic liver disease: An evolution from child to MELD
-
L.M. Forman, and M.R. Lucey Predicting the prognosis of chronic liver disease: an evolution from child to MELD Hepatology 33 2001 473 475
-
(2001)
Hepatology
, vol.33
, pp. 473-475
-
-
Forman, L.M.1
Lucey, M.R.2
-
10
-
-
0037232566
-
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis
-
H.W. Hann, R.J. Fontana, T. Wright, G. Everson, A. Baker, E.R. Schiff, C. Riely, G. Anschuetz, S.D. Gardner, N. Brown, and D. Griffiths A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis Liver Transpl. 9 1 2003 49 56
-
(2003)
Liver Transpl.
, vol.9
, Issue.1
, pp. 49-56
-
-
Hann, H.W.1
Fontana, R.J.2
Wright, T.3
Everson, G.4
Baker, A.5
Schiff, E.R.6
Riely, C.7
Anschuetz, G.8
Gardner, S.D.9
Brown, N.10
Griffiths, D.11
-
11
-
-
0036230551
-
Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation
-
A.Y. Hui, H.L. Chan, N.W. Leung, L.C. Hung, F.K. Chan, and J.J. Sung Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation J. Clin. Gastroenterol. 34 5 2002 569 572
-
(2002)
J. Clin. Gastroenterol.
, vol.34
, Issue.5
, pp. 569-572
-
-
Hui, A.Y.1
Chan, H.L.2
Leung, N.W.3
Hung, L.C.4
Chan, F.K.5
Sung, J.J.6
-
12
-
-
0033931789
-
Beneficial effects of lamivudine in hepatitis B virus related decompensated liver cirrhosis
-
D. Kapoor, R. Guptan, S. Wakil, S. Kazim, R. Kaul, S.R. Aganwal, D. Kapoor, R.C. Guptan, S.M. Wakil, S.N. Kazim, R. Kaul, S.R. Agarwal, S. Raisuddin, S.E. Hasnain, and S.K. Sarin Beneficial effects of lamivudine in hepatitis B virus related decompensated liver cirrhosis J. Hepatol. 33 2000 308 312
-
(2000)
J. Hepatol.
, vol.33
, pp. 308-312
-
-
Kapoor, D.1
Guptan, R.2
Wakil, S.3
Kazim, S.4
Kaul, R.5
Aganwal, S.R.6
Kapoor, D.7
Guptan, R.C.8
Wakil, S.M.9
Kazim, S.N.10
Kaul, R.11
Agarwal, S.R.12
Raisuddin, S.13
Hasnain, S.E.14
Sarin, S.K.15
-
13
-
-
84873889036
-
Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures
-
Y.J. Kim, D.H. Sinn, G.Y. Gwak, M.S. Choi, K.C. Koh, S.W. Paik, B.C. Yoo, and J.H. Lee Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures World J. Gastroenterol. 18 2012 6996 7002
-
(2012)
World J. Gastroenterol.
, vol.18
, pp. 6996-7002
-
-
Kim, Y.J.1
Sinn, D.H.2
Gwak, G.Y.3
Choi, M.S.4
Koh, K.C.5
Paik, S.W.6
Yoo, B.C.7
Lee, J.H.8
-
14
-
-
0024391690
-
Natural course after the development of cirrhosis in patients with chronic type B hepatitis: A prospective study
-
Y.F. Liaw, D.Y. Lin, T.J. Chen, and C.M. Chu Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study Liver 9 4 1989 235 241
-
(1989)
Liver
, vol.9
, Issue.4
, pp. 235-241
-
-
Liaw, Y.F.1
Lin, D.Y.2
Chen, T.J.3
Chu, C.M.4
-
15
-
-
78751491184
-
Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF and entecavir in patients with decompensated chronic hepatitis liver disease
-
Y.F. Liaw, I.S. Sheen, C.M. Lee, U.S. Akarca, G.V. Papatheodoridis, S.H. Wong, T.T. Chang, A. Horban, C. Wang, P. Kwan, M. Buti, M. Prieto, T. Berg, K. Kitrinos, K. Peschell, E. Mondou, D. Frederick, F. Rousseau, and E.R. Schiff Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF and entecavir in patients with decompensated chronic hepatitis liver disease Hepatology 53 2011 62 72
-
(2011)
Hepatology
, vol.53
, pp. 62-72
-
-
Liaw, Y.F.1
Sheen, I.S.2
Lee, C.M.3
Akarca, U.S.4
Papatheodoridis, G.V.5
Wong, S.H.6
Chang, T.T.7
Horban, A.8
Wang, C.9
Kwan, P.10
Buti, M.11
Prieto, M.12
Berg, T.13
Kitrinos, K.14
Peschell, K.15
Mondou, E.16
Frederick, D.17
Rousseau, F.18
Schiff, E.R.19
-
16
-
-
0033027690
-
Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection
-
S.M. Lin, I.S. Sheen, R.N. Chien, C.M. Chu, and Y.F. Liaw Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection Hepatology 29 1999 971 975
-
(1999)
Hepatology
, vol.29
, pp. 971-975
-
-
Lin, S.M.1
Sheen, I.S.2
Chien, R.N.3
Chu, C.M.4
Liaw, Y.F.5
-
17
-
-
24344478565
-
Molecular virology and the development of resistant mutants: Implications for therapy
-
S. Locarnini Molecular virology and the development of resistant mutants: implications for therapy Semin. Liver Dis. 25 1 2005 9 19
-
(2005)
Semin. Liver Dis.
, vol.25
, Issue.1
, pp. 9-19
-
-
Locarnini, S.1
-
18
-
-
10744225554
-
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
-
A.S. Lok, C.L. Lai, N. Leung, G.B. Yao, Z.Y. Cui, E.R. Schiff, J.L. Dienstag, E.J. Heathcote, N.R. Little, D.A. Griffiths, S.D. Gardner, and M. Castiglia Long-term safety of lamivudine treatment in patients with chronic hepatitis B Gastroenterology 125 2003 1714 1722
-
(2003)
Gastroenterology
, vol.125
, pp. 1714-1722
-
-
Lok, A.S.1
Lai, C.L.2
Leung, N.3
Yao, G.B.4
Cui, Z.Y.5
Schiff, E.R.6
Dienstag, J.L.7
Heathcote, E.J.8
Little, N.R.9
Griffiths, D.A.10
Gardner, S.D.11
Castiglia, M.12
-
19
-
-
70349240414
-
Chronic hepatitis B: Update
-
A.S. Lok, and B.J. McMahon Chronic hepatitis B: update Hepatology 50 3 2009 661 662
-
(2009)
Hepatology
, vol.50
, Issue.3
, pp. 661-662
-
-
Lok, A.S.1
McMahon, B.J.2
-
20
-
-
0034106289
-
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
-
M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, J. Rank, and P.L. Terborg A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 31 2000 864 871
-
(2000)
Hepatology
, vol.31
, pp. 864-871
-
-
Malinchoc, M.1
Kamath, P.S.2
Gordon, F.D.3
Peine, C.J.4
Rank, J.5
Terborg, P.L.6
-
21
-
-
0025761281
-
Assessment of pretransplant prognosis in patients with cirrhosis
-
M. Oellerich, M. Burdelski, H.U. Lautz, B. Rodeck, J. Duewel, M. Schulz, F.W. Schmidt, J. Brodehl, and R. Pichlmayr Assessment of pretransplant prognosis in patients with cirrhosis Transplantation 51 4 1991 801 806
-
(1991)
Transplantation
, vol.51
, Issue.4
, pp. 801-806
-
-
Oellerich, M.1
Burdelski, M.2
Lautz, H.U.3
Rodeck, B.4
Duewel, J.5
Schulz, M.6
Schmidt, F.W.7
Brodehl, J.8
Pichlmayr, R.9
-
22
-
-
0015854966
-
Transection of the oesophagus for bleeding oesophageal varices
-
R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br. J. Surg. 60 1973 646 649
-
(1973)
Br. J. Surg.
, vol.60
, pp. 646-649
-
-
Pugh, R.N.1
Murray-Lyon, I.M.2
Dawson, J.L.3
Pietroni, M.C.4
Williams, R.5
-
23
-
-
33947427581
-
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results
-
E. Schiff, C.L. Lai, S. Hadziyannis, P. Neuhaus, N. Terrault, M. Colombo, H. Tillmann, D. Samuel, S. Zeuzem, J.P. Villeneuve, S. Arterburn, K. Borroto-Esoda, C. Brosgart, and S. Chuck Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results Liver transpl. 13 2007 349 360
-
(2007)
Liver Transpl.
, vol.13
, pp. 349-360
-
-
Schiff, E.1
Lai, C.L.2
Hadziyannis, S.3
Neuhaus, P.4
Terrault, N.5
Colombo, M.6
Tillmann, H.7
Samuel, D.8
Zeuzem, S.9
Villeneuve, J.P.10
Arterburn, S.11
Borroto-Esoda, K.12
Brosgart, C.13
Chuck, S.14
-
24
-
-
75349107764
-
Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis
-
J.H. Shim, H.C. Lee, K.M. Kim, Y.S. Lim, Y.H. Chung, Y.S. Lee, and D.J. Suh Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis J. Hepatol. 52 2010 176 182
-
(2010)
J. Hepatol.
, vol.52
, pp. 176-182
-
-
Shim, J.H.1
Lee, H.C.2
Kim, K.M.3
Lim, Y.S.4
Chung, Y.H.5
Lee, Y.S.6
Suh, D.J.7
-
25
-
-
21844433214
-
Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis
-
P.L. Tseng, S.N. Lu, H.D. Tung, J.H. Wang, C.S. Changchien, and C.M. Lee Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis J. Viral Hepat. 12 2005 386 392
-
(2005)
J. Viral Hepat.
, vol.12
, pp. 386-392
-
-
Tseng, P.L.1
Lu, S.N.2
Tung, H.D.3
Wang, J.H.4
Changchien, C.S.5
Lee, C.M.6
-
26
-
-
0346099109
-
Chronic hepatitis B - A long term retrospective cohort study of disease progression in Shanghai
-
B. Xu, D.C. Hu, D.M. Rosenberg, Q.W. Jiang, X.M. Lin, J.L. Lu, and N.J. Robinson Chronic hepatitis B - a long term retrospective cohort study of disease progression in Shanghai China J. Gastroenterol. Hepatol. 18 12 2003 1345 1352
-
(2003)
China J. Gastroenterol. Hepatol.
, vol.18
, Issue.12
, pp. 1345-1352
-
-
Xu, B.1
Hu, D.C.2
Rosenberg, D.M.3
Jiang, Q.W.4
Lin, X.M.5
Lu, J.L.6
Robinson, N.J.7
-
27
-
-
0033929544
-
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
-
F.Y. Yao, and N.M. Bass Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection J. Hepatol. 33 2000 301 307
-
(2000)
J. Hepatol.
, vol.33
, pp. 301-307
-
-
Yao, F.Y.1
Bass, N.M.2
-
28
-
-
0034927065
-
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
-
F.Y. Yao, N.A. Terrault, C.E. Friese, L. Maslow, and N.M. Bass Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort Hepatology 34 2001 411 416
-
(2001)
Hepatology
, vol.34
, pp. 411-416
-
-
Yao, F.Y.1
Terrault, N.A.2
Friese, C.E.3
Maslow, L.4
Bass, N.M.5
-
29
-
-
0000194942
-
Model for end-stage liver disease (MELD). Dynamic change in MELD score is important in predicting mortality for patients awaiting liver transplantation (LTX)
-
254A
-
M.M. Yousfi, D.D. Douglas, and E. Harrison Model for end-stage liver disease (MELD). Dynamic change in MELD score is important in predicting mortality for patients awaiting liver transplantation (LTX) Hepatology 34 2001 254A
-
(2001)
Hepatology
, vol.34
-
-
Yousfi, M.M.1
Douglas, D.D.2
Harrison, E.3
-
30
-
-
84887415583
-
-
World-Health-Organization, August 2008 Revision. Hepatitis B. Fact sheet no. 204. accessed 01.02.2013
-
World-Health-Organization, August 2008 Revision. Hepatitis B. Fact sheet no. 204. < http://www.who.int/mediacentre/factsheets/fs204/en/ >. (accessed 01.02.2013.
-
-
-
|